Pineal Tetrapeptide · Ala-Glu-Asp-Gly · Protocol Guide
Epithalon: The Honest Telomere Peptide Guide
Epithalon (Epitalon, AEDG) is a four-amino-acid peptide modeled on a pineal gland extract. The telomerase story is real but rests almost entirely on small Russian studies that the West has not replicated. This guide draws that line in plain sight.
- FDA Status
- Investigational, 503A Compounded
- Pharmacy
- Optimal Balance Pharmacy (503A licensed)
- Medical Service
- RxPepsDirect, physician-supervised
- Access
- 28 U.S. States
Our promise: Almost every claim about Epithalon traces back to one research group in St. Petersburg. The telomerase result is from a cell-culture study, the lifespan results are from flies and mice, and the human longevity trial used the pineal extract Epithalamin combined with a second peptide, not pure Epithalon. We say exactly where the evidence is strong, where it is thin, and where it simply does not exist.
Medically reviewed by Dr. Jonathan Snipes, MD. Last reviewed June 8, 2026.On this page
Section 01
What Epithalon Actually Is
Epithalon, also spelled Epitalon and abbreviated AEDG, is a synthetic four-amino-acid peptide: alanine, glutamic acid, aspartic acid, glycine (Ala-Glu-Asp-Gly). It was designed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology, built to match the amino acid content of Epithalamin, an extract of the pineal gland from cattle. The idea was to distill a complex glandular extract down to a short, defined peptide that could be made reproducibly.
The pineal gland sits at the center of this story. It is the small structure that makes melatonin and helps run the body's daily and seasonal rhythms. Khavinson's group framed aging as a gradual loss of the regulatory peptides that organs use to keep gene expression on track, and proposed that a pineal-derived tetrapeptide could help restore some of that signaling. Epithalon is the molecule built from that premise.
What Epithalon is not is just as important. It is not a hormone, it is not melatonin, and it does not raise testosterone or growth hormone. It produces no reliable felt effect the way a GH secretagogue or a neuroactive peptide does. The claims attached to it, telomere maintenance and slowed cellular aging, are mechanistically interesting but rest on a narrow and largely unreplicated body of work.
4
Amino acids (Ala-Glu-Asp-Gly), modeled on the pineal extract Epithalamin
2003
Year the human-cell telomerase result was published (in vitro)
266
Patients in the most-cited human trial, which used Epithalamin extract, not pure Epithalon
503A
Pathway for U.S. compounded access under physician prescription
Section 02
Who It Is Actually For
Epithalon is a longevity-curious compound, not a treatment for any condition. Nobody studied here had a disease being cured. The honest framing is that most use is exploratory, justified by mechanism and animal data rather than human outcomes.
| Profile | Primary Motivation | Evidence Basis | Fit |
|---|---|---|---|
| Longevity-Focused Adult | Cellular aging support, telomere maintenance interest | Cell-culture telomerase signal plus animal lifespan data. No human telomere or lifespan trial of pure Epithalon. | Exploratory |
| Older Adult Seeking General Resilience | Immune, cardiovascular, and metabolic resilience with age | The 266-patient trial used Epithalamin extract, often with Thymalin, not pure Epithalon. | Indirect Evidence |
| Sleep and Circadian Interest | Better sleep through the pineal and melatonin connection | Mechanistically plausible, anecdotal in humans, not consistently shown in controlled work. | Plausible, Unproven |
| General Anti-Aging / Biohacking Use | Broad slowing of cellular aging | Extrapolated from preclinical models. Not a tested human outcome. | Speculative |
| Active or History of Hormone-Sensitive Cancer | Any use | Animal data is anticarcinogenic, but human cancer safety is untested. Caution is the only honest stance. | Discuss With Prescriber First |
Profile
Primary Motivation
Evidence Basis
Fit
Profile
Primary Motivation
Evidence Basis
Fit
Profile
Primary Motivation
Evidence Basis
Fit
Profile
Primary Motivation
Evidence Basis
Fit
Profile
Primary Motivation
Evidence Basis
Fit
Section 03
How Epithalon Works
The proposed mechanism is unusual. Rather than binding a single surface receptor, Epithalon is thought to act inside the cell, on gene expression itself. Khavinson's group has argued the short sequence can interact with regions of DNA and influence which genes are switched on, including the gene for telomerase. That is a strong claim, and it is worth holding it loosely until independent labs confirm the details.
Telomerase Reactivation
In a 2003 cell-culture study, adding Epithalon to telomerase-negative human fetal fibroblasts switched the telomerase gene back on and lengthened telomeres in the dish. This is the single most cited mechanistic result, and it is in vitro, not in living people.
Gene Expression Modulation
Microarray work from the same program reported that Epithalon changed the expression of dozens of genes in tissue. The proposal is that the peptide nudges aging cells back toward a more youthful pattern of gene activity, though the precise targets in humans are not established.
Pineal and Melatonin Signaling
Epithalon was built from a pineal extract, and animal work links it to restored melatonin rhythms in old animals. This is the basis for the better-sleep reports, though human sleep data is anecdotal rather than trial-grade.
Antioxidant and Immune Effects
In animals, Epithalon and the parent extract have been linked to antioxidant defense and immune normalization with age. These are supporting mechanisms in the geroprotector hypothesis, not standalone proven human benefits.
Section 04
What the Evidence Shows
This is the section that matters most for Epithalon, because the distance between the marketing and the proof is wide. Here is the actual record, in order, with the limitations stated rather than buried. According to PubMed:
| Study | Design | Key Finding | Strength |
|---|---|---|---|
| Khavinson 2003 (Bull Exp Biol Med) [2] | In vitro, human fetal fibroblast culture | Epithalon switched on telomerase and lengthened telomeres in the dish. | Cell Culture, Single Lab |
| Khavinson 2003 (Neuro Endocrinol Lett) [3] | 266 elderly patients, 6 to 8 years, Epithalamin extract, often with Thymalin | Reported lower mortality and improved cardiovascular, immune, and metabolic indices versus control. | Human, But Extract Not Pure Peptide |
| Anisimov 2003 (Biogerontology) [4] | Female SHR mice, monthly courses for life | Increased maximum lifespan and reduced chromosome aberrations and leukemia, no change in mean lifespan. | Animal Geroprotector |
| Khavinson 2000 (Mech Ageing Dev) [5] | Drosophila (fruit fly) lifespan | Increased lifespan by 11 to 16 percent at very low doses. | Invertebrate Model |
| Araj 2025 review (Int J Mol Sci) [1] | Modern narrative review | Summarizes geroprotective and neuroendocrine effects while flagging mechanistic uncertainty and limited structural data. | Recent Independent Review |
Study
Design
Key Finding
Strength
Study
Design
Key Finding
Strength
Study
Design
Key Finding
Strength
Study
Design
Key Finding
Strength
Study
Design
Key Finding
Strength
Section 05
The Telomerase Question
Telomeres are the protective caps on the ends of chromosomes. They shorten a little each time a cell divides, and that shortening is one of the recognized hallmarks of aging. Telomerase is the enzyme that can rebuild them. The entire appeal of Epithalon is the claim that it switches telomerase back on. It is worth understanding precisely what was shown and what was not.
What was shown: in a 2003 study [2], adding Epithalon to a culture of telomerase-negative human fetal fibroblasts induced telomerase activity and lengthened the telomeres of those cells in the dish. That is a genuine, specific result. What was not shown: that the same thing happens in a living person who injects Epithalon. No published human study has measured telomere lengthening after Epithalon use.
Section 06
Realistic Expectations
Epithalon is a quiet, long-horizon compound with no day-one effect. If it does anything, it does so at the level of cellular aging, which is invisible to you in real time. Set expectations accordingly.
No Felt Effect
Expect to feel nothing obvious. Epithalon is proposed to act on gene expression and cellular maintenance, not on receptors that produce a noticeable subjective response. Some users report slightly better sleep in this window, which is plausible given the pineal link but is anecdotal.
Subtle Subjective Reports
The most commonly reported user experiences (better sleep, a vague sense of wellbeing) tend to surface here if they surface at all. None of this is validated by controlled human data, and it is just as likely to be expectation as effect.
No Visible Endpoint
Unlike a fat-loss or recovery peptide, Epithalon offers no measurable result you can see at the end of a course. Telomere testing exists but is noisy and not a validated way to confirm a response to this peptide. You finish a course on the calendar, not on a felt milestone.
An Act of Faith in the Mechanism
Continued or repeated use is ultimately a bet on the geroprotector hypothesis rather than on a benefit you can verify in yourself. That is a legitimate personal choice, but it should be made with eyes open about how thin the human proof is.
Section 07
Dosing Protocol
Epithalon is given by subcutaneous injection. The original research protocols used short pulsed courses; the common home protocol is a daily injection over a number of weeks. Your RxPepsDirect physician sets the course and the dose. The numbers below are the catalog standard and the historical research range, not a personal recommendation.
| Context | Dose | Route / Frequency | Evidence Basis |
|---|---|---|---|
| RxPepsDirect Standard | 0.5 mg (25 units) | Subcutaneous, daily Monday to Friday, 8 to 12 weeks | Clinical Practice |
| High-Dose Vial | 2.5 mg (25 units at 10 mg/mL) | Subcutaneous, daily Monday to Friday, provider-guided | Experienced Users Only |
| Classic Pulsed Course | Short daily course | Subcutaneous, daily for roughly 10 to 20 days, repeated periodically | Historical Research Pattern |
| GHK-Cu + Epithalon Combo | 0.4 mg Epithalon (with 2 mg GHK-Cu) | Subcutaneous, daily Monday to Friday, single vial | Convenience Combination |
Context
Dose
Route / Frequency
Evidence Basis
Context
Dose
Route / Frequency
Evidence Basis
Context
Dose
Route / Frequency
Evidence Basis
Context
Dose
Route / Frequency
Evidence Basis
Subcutaneous injection into abdominal fat with a standard insulin syringe (28 to 31 gauge, 6 to 8 mm needle). Rotate sites. Timing is flexible because Epithalon does not align with any hormonal pulse, though many users dose in the evening to lean into the pineal and sleep connection. Note the gap between the conservative catalog dose and the various historical protocols: your prescriber decides where to land based on your goals, the vial concentration, and your tolerance.
Section 08
Ready to Inject
0
Reconstitution steps required
503A
Licensed pharmacy (Optimal Balance), physician-supervised
Overnight
FedEx shipping in a reusable cooled travel case
Section 09
Safety and Side Effects
Epithalon is generally described as well tolerated in the animal studies and in user reports, with no toxic effects noted even with long-term low-dose administration in mice. The honest caveat is that this reassurance rests on animal data and uncontrolled human experience, not on rigorous human safety trials.
| Consideration | Detail | Action |
|---|---|---|
| Injection site reaction | Mild redness or sting, the most commonly noted event | Rotate sites. Let the vial warm slightly before injecting. |
| Hormone-sensitive or active cancer | Epithalon is proposed to reactivate telomerase, and human cancer safety is untested | Discuss your full cancer history with your prescriber before use. |
| Pregnancy / lactation | No safety data | Avoid. |
| Anti-doping tested athletes | Non-approved substance, WADA S0 category | Confirm with your governing body before use. |
Consideration
Detail
Action
Consideration
Detail
Action
Consideration
Detail
Action
Consideration
Detail
Action
Section 10
Stacking
Pairs Well With
GHK-Cu
Copper-peptide gene-expression rejuvenation alongside Epithalon's telomere angle. The two are offered as a single combination vial for a streamlined longevity protocol.
NAD+
Mitochondrial and cellular-energy support paired with the telomere mechanism. A common multi-pathway longevity pairing. Independent timing.
MOTS-c
Mitochondrial-derived peptide for metabolic and exercise-capacity support. Complementary aging pathway, no timing conflict.
Avoid or Use Caution
Use during active cancer or chemotherapy
A telomerase-reactivating peptide is the wrong context here. Discuss with your oncologist and prescriber before any consideration.
Pregnancy / lactation
No safety data. Avoid.
Section 11
Pricing
Pharmacy: Medication
$80/10mg per vial for standard Epithalon, or $130/50mg for the high-dose vial. Compounded and shipped by Optimal Balance Pharmacy, a 503A licensed compounding pharmacy. Pre-reconstituted, FedEx overnight.
Medical Service: Physician Consultation
$39 medical visit fee. Intake consultation including history review, contraindication screening, protocol design, prescription writing, and follow-up. Billed by RxPepsDirect for the medical service only.
Section 12
Legal Access in 28 States
503A Licensed Pharmacy
Optimal Balance Pharmacy, U.S. licensed
Physician Prescription Required
Compounded medication, Rx only
Investigational Compound
Preclinical and limited human data, no FDA approval
Off-Label, Legal Practice
Standard and legal in U.S. medicine
Epithalon is an investigational peptide. It has never been FDA-approved for any indication. In the United States it is available through 503A patient-specific compounding under a physician prescription. The 503A pathway is the documented legal route for compounded peptide access. RxPepsDirect prescribers serve patients in 28 states.
Section 13
Community Q&A
Does Epithalon actually lengthen my telomeres?
The evidence that it can is a single cell-culture study from 2003, in which adding Epithalon to human fetal fibroblasts switched telomerase back on and extended telomeres in the dish. That is a real result, but it is in vitro, from one Russian laboratory, and not reproduced independently. No published trial has measured telomere lengthening in living humans who took Epithalon. Treat it as a lab finding, not a proven outcome.
Is the human evidence actually strong?
No. The most cited human study followed 266 elderly patients and reported lower mortality, but it used Epithalamin (the pineal extract), often combined with a second peptide, Thymalin, not pure Epithalon. The lifespan numbers people quote are from fruit flies and mice. Most work comes from one St. Petersburg group, and the West has not replicated it.
Will I feel anything?
Usually not dramatically. Some users report better sleep, which fits the pineal connection but is subjective and not consistently shown in controlled work. Epithalon is proposed to act slowly on cellular aging, so there is no day-one effect to chase.
Is it safe given the telomerase claim?
Reactivating telomerase is the same trick cancers use to divide without limit, so a telomerase-targeting peptide warrants respect. The animal data on Epithalon is actually anticarcinogenic, which is reassuring, but human cancer safety is untested. Anyone with a cancer history should discuss it with their prescriber first.
How long is a course?
The original research used short pulsed courses of roughly 10 to 20 days, repeated periodically. The common home and catalog protocol is a daily injection Monday to Friday over 8 to 12 weeks, which may be cycled or extended with your prescriber.
Section 14
The RxPepsDirect Model
Pharmacy: Optimal Balance, 503A Licensed
Optimal Balance Pharmacy compounds your Epithalon under a patient-specific prescription, USP <797> sterile standards, and federal 503A oversight.
Medical Service: RxPepsDirect Physicians
A licensed physician reviews your history, screens for contraindications, designs your course, and writes your prescription. RxPepsDirect bills the $39 medical visit fee for this service.
Transparent Safety Communication
This guide flags that the human evidence is thin, that the telomerase result is in vitro, that the lifespan data is from flies and mice, that the human trial used an extract rather than the pure peptide, and that the work is largely unreplicated. We do not hide limitations to make a sale.
Legal Access in 28 States
Every shipment is a compounded prescription medication filled by a 503A licensed pharmacy under a physician prescription.
References
- Araj SK, Brzezik J, Madra-Gackowska K, Szeleszczuk L. Overview of Epitalon: highly bioactive pineal tetrapeptide with promising properties. Int J Mol Sci. 2025. PMID: 40141333
- Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003. PMID: 12937682
- Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett. 2003. PMID: 14523363
- Anisimov VN, Khavinson VKh, Popovich IG, Zabezhinski MA, Alimova IN, et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003. PMID: 14501183
- Khavinson VK, Izmaylov DM, Obukhova LK, Malinin VV. Effect of epitalon on the lifespan increase in Drosophila melanogaster. Mech Ageing Dev. 2000. PMID: 11087911
- Khavinson VKh. Peptides and Ageing. Neuro Endocrinol Lett. 2002. PMID: 12374906
Related protocol guides
Other protocols in the same clinical territory. Each guide is co-bylined by a licensed RxPepsDirect prescriber.
Longevity coenzyme
NAD+ protocol guide: sirtuin activation, the bioavailability problem, and IV vs subcutaneous
Oral supplements have a bioavailability problem the marketing rarely admits. IV produces the flush. Subcutaneous is the at-home middle ground. Not proven to extend lifespan.
Mitochondrial-derived peptide (metabolic)
MOTS-c protocol guide: AMPK activation, the WADA prohibition, and the human evidence gap
Strong rodent data, thin human RCT data. AMPK activator (different mechanism than metformin). WADA prohibited since 1/1/2025. Not an exercise substitute.
Mitochondria-targeted tetrapeptide
Elamipretide (SS-31) guide: cardiolipin-stabilizing mitochondria-targeted peptide
Cleanest mechanism in the mitochondrial-support category. Late-stage FDA program (Barth syndrome). Phase III ReCLAIM-2 missed primary endpoint. Available through 503A compounding.
Continue reading